bluebird bio, Inc. (BLUE) financial statements (2021 and earlier)

Company profile

Business Address 60 BINNEY STREET
CAMBRIDGE, MA 02142
State of Incorp. DE
Fiscal Year End December 31
SIC 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments1,1571,1061,3851,290704518474
Cash and cash equivalents318327403759279164348
Short-term investments839779983532425354126
Restricted cash and investments2      
Prepaid expense37332021   
Other undisclosed current assets201314112066
Total current assets:1,2161,1521,4191,323724524480
Noncurrent Assets
Operating lease, right-of-use asset184186
Property, plant and equipment1631512472001578316
Long-term investments and receivables12313250632418034818
Long-term investments12313250632418034818
Intangible assets, net (including goodwill)23272630343841
Goodwill13131313131313
Intangible assets, net (excluding goodwill)10141317212428
Other noncurrent assets7379452423101
Total noncurrent assets:56657582457839447877
TOTAL ASSETS:1,7811,7272,2431,9011,1181,002557
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities10011518131468
Accounts payable224318131463
Accrued liabilities2227    0
Employee-related liabilities5645    5
Deferred revenue28
Debt 20     
Business combination, contingent consideration, liability      0
Deferred revenue and credits266626
Contract with customer, liability19
Other liabilities  995755281
Other undisclosed current liabilities1028011   7
Total current liabilities:20422414696754043
Noncurrent Liabilities
Long-term debt and lease obligation168171     
Operating lease, liability168171
Liabilities, other than long-term debt33202527545023
Deferred revenue and credits24514414
Deferred revenue2610
Contract with customer, liability16
Deferred tax liabilities, net    2
Other liabilities7230000
Business combination, contingent consideration, liability 852356
Other undisclosed noncurrent liabilities222818715512062 
Total noncurrent liabilities:22321921118217411123
Total liabilities:42644235827724915265
Stockholders' equity
Stockholders' equity attributable to parent1,3551,2851,8851,623869850491
Common stock1110000
Additional paid in capital4,2603,5683,3872,5411,4481,167638
Accumulated other comprehensive loss(6)(2)(4)(4)(1)(2)(0)
Accumulated deficit(2,901)(2,282)(1,499)(914)(578)(314)(147)
Total stockholders' equity:1,3551,2851,8851,623869850491
TOTAL LIABILITIES AND EQUITY:1,7811,7272,2431,9011,1181,002557

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Revenues25145553561425
Revenue, net2261425
Cost of revenue(5)(6)(1)    
Cost of goods and services sold(5)(3)(1)    
Gross profit:24539543561425
Operating expenses(875)(854)(627)(368)(274)(183)(90)
Other undisclosed operating income6 1   4
Operating loss:(623)(815)(572)(332)(268)(169)(61)
Nonoperating income (expense)(7)(10)2(1)420
Investment income, nonoperating     20
Foreign currency transaction loss, before tax      (0)
Other nonoperating income (expense)(7)(10)2(1)410
Loss from continuing operations before equity method investments, income taxes:(630)(825)(570)(333)(264)(167)(61)
Other undisclosed income (loss) from continuing operations before income taxes123515(2)   
Loss from continuing operations before income taxes:(618)(790)(555)(335)(264)(167)(61)
Income tax expense (benefit)(1)1(0)(0)1(0)12
Net loss available to common stockholders, diluted:(619)(790)(556)(336)(264)(167)(49)

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Net loss:(619)(790)(556)(336)(264)(167)(49)
Other comprehensive income (loss)(4)21(3)1(2)(0)
Comprehensive loss, net of tax, attributable to parent:(622)(788)(555)(339)(262)(169)(49)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: